Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsLocally Advanced Solid Tumors; Metastatic Solid Tumors; Recurrent Solid TumorsActive, not recruitingPhase 12026-07-28NCT06031441

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genentech, Inc.221

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's HospitalCambridgeUnited Kingdom40
British Columbia Cancer Agency - 600 10th Ave WVancouverCanada1
Churchill HospitalOxfordUnited Kingdom9
Icahn School of Medicine at Mount Sinai (ISMMS)New YorkUnited States5
Leicester Royal InfirmaryLeicesterUnited Kingdom35
Magee-Woman's HospitalHarrisburgUnited States1
National Cancer CentreSingaporeSingapore13
National University HospitalSingaporeSingapore55
Peter MacCallum Cancer CentreMelbourneAustralia149
Princess Margaret Cancer CentreTorontoCanada14
Sarah Cannon Research InstituteLondonUnited Kingdom15
Scri Oncology PartnersNashvilleUnited States156
St Bartholomew's HospitalLondonUnited Kingdom40
St Vincent's Hospital SydneyDarlinghurstAustralia30
The Ohio State UniversityColumbusUnited States1
The Royal Marsden HospitalSuttonUnited Kingdom14
University of Alabama at Birmingham (UAB)BirminghamUnited States1
Yale Cancer CenterNew HavenUnited States31